Copy
Auvi-Q epinephrine injection
Sponsored by Aimmune Therapeutics
Your first source for news that matters to you. Oct. 31, 2022

ADVOCACY INSIDER

HEALTH BEHAVIOR ASSESSMENT CODES 96160 AND 96161

 
When can allergists use them?

College Solutions

Watch our recent webinar for experts’ tips on what to include in your documentation to support your claims. Free for members!  

PARTICIPATE IN THE 2022 ANNUAL MEETING FROM YOUR HOME OR OFFICE

 
Not traveling to Louisville? Get the education you’re looking for with our Livestream program. Hurry! Register for Livestream by Nov. 9.

NEW! CAP REVIEW IS NOW ONLINE

 
The Continuous Assessment Program (CAP) Review Session has been pre-recorded and is available now.

HOUSE OF DELEGATES THIRD QUARTER UPDATE

 

College Learning Connection

In less than 25 minutes, get an overview of generalized dermatitis. Our MicroCME modules are free for members!

GOOD READS | OUR SPECIALTY IN THE NEWS


ACAAI in the news: James Corden: Concern about wife's 'serious allergy' to omelet dish sparks new questions

MIPS Automatic Extreme and Uncontrollable Circumstances (EUC) applied for Puerto Rico and Florida

MGMA: Amid staffing shortages, it's time to help patients help themselves via self-service tools

2022 MIPS exception applications are available for the Extreme and Uncontrollable Circumstances (EUC) exception and the Promoting Interoperability Performance Category Hardship Exception. Applications for both are available until Jan. 3, 2023.

    
         
Learn More Prescribing Information, including Boxed WARNING and Medication Guide Palforzia

THANKS TO OUR 2022 PREMIER PARTNERS

DIAMOND
$500,000+
Sanofi Regeneron
PLATINUM
$300,000 –
$499,999
AstraZeneca DBV GSK
blank Takeda
GOLD
$100,000 –
$299,999
abbvie aimmune Amgen
blank Genentech Incyte Pharming
blank Pfizer Stallergenes Greer
blank Teva
SILVER
$50,000 –
$99,999
ALK Biocryst COVIS
 
blank Novartis Optinose
Copyright © 2022 American College of Allergy, Asthma and Immunology, All rights reserved.


View this email online or if you wish to no longer receive these emails, unsubscribe from this list